Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology(TM) Oncology Platform
Stock Information for Theratechnologies Inc.
Loading
Please wait while we load your information from QuoteMedia.